Iopidine

Apraclonidine, the active ingredient in Iopidine, is a alpha-2 adrenergic agonist presented as eye drops for ocular use. It lowers intraocular pressure and is employed in the management of glaucoma and ocular hypertension. GNH USA supplies Iopidine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Apraclonidine (Iopidine) is used in ocular hypotensive therapy to lower intraocular pressure.

Open‑angle glaucoma: reduces intraocular pressure to prevent optic‑nerve damage. Ocular hypertension: lowers eye pressure to reduce risk of progression to glaucoma. Post‑operative ocular hypertension: helps control pressure spikes after eye surgery.

Common Side Effects: - Burning or stinging sensation upon instillation. - Conjunctival hyperemia (redness of the eye). - Transient blurred vision. - Dry eye sensation. - Mild ocular itching. - Temporary foreign‑body feeling.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema, anaphylaxis). - Significant systemic hypotension. - Persistent ocular inflammation or uveitis. - Corneal edema or keratitis. - Acute vision loss. - Severe eye pain not relieved by standard measures.

Before using Iopidine, consider the following precautions: - Pregnancy: safety not established; use only if potential benefit justifies the risk. - Breastfeeding: unknown excretion; weigh benefits against possible infant exposure. - Concurrent ocular hypotensives: monitor intraocular pressure for additive effects. - Cardiovascular disease: observe for systemic hypotensive effects. - Avoid contaminating the dropper tip; do not touch the eye or surrounding tissues with the bottle. - Store at room temperature: keep in original container, protect from light and moisture.

Apraclonidine may interact with other medicines as follows.

Major Interactions (Avoid): - Other alpha‑2 agonists (e.g., clonidine): risk of additive systemic hypotension. - Systemic beta‑blockers: may enhance ocular pressure‑lowering effect excessively. - Monoamine oxidase inhibitors: potential for heightened adrenergic responses.

Moderate Interactions (Monitor Closely):\n- Topical anesthetics: may increase ocular irritation. - Non‑steroidal anti‑inflammatory eye drops: monitor for inflammation. - Systemic antihypertensives: observe blood pressure for additive lowering.